{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:32:26Z","timestamp":1774445546004,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2025ZZTS0172"],"award-info":[{"award-number":["2025ZZTS0172"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300787"],"award-info":[{"award-number":["82300787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50519"],"award-info":[{"award-number":["2025JJ50519"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04822-3","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:37:55Z","timestamp":1771324675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy"],"prefix":"10.1186","volume":"27","author":[{"given":"Jiawei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhe","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangzhe","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"3","key":"4822_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN. IgA nephropathy: core curriculum 2021. AM J KIDNEY DIS. 2021;78(3):429\u201341.","journal-title":"AM J KIDNEY DIS"},{"issue":"4","key":"4822_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M, Reich HN. IgA nephropathy. CLIN J AM SOC NEPHRO. 2017;12(4):677\u201386.","journal-title":"CLIN J AM SOC NEPHRO"},{"issue":"5","key":"4822_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","volume":"43","author":"J Floege","year":"2021","unstructured":"Floege J, Rauen T, Tang S. Current treatment of IgA nephropathy. SEMIN IMMUNOPATHOL. 2021;43(5):717\u201328.","journal-title":"SEMIN IMMUNOPATHOL"},{"issue":"9","key":"4822_CR4","first-page":"694","volume":"74","author":"J Berger","year":"1968","unstructured":"Berger J, Hinglais N. [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris). 1968;74(9):694\u20135.","journal-title":"J Urol Nephrol (Paris)"},{"key":"4822_CR5","doi-asserted-by":"publisher","first-page":"1336402","DOI":"10.3389\/fendo.2024.1336402","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Du B, Zhu X, Wang Y, Zheng H, Liu W. Lipid metabolism disorder in diabetic kidney disease. FRONT ENDOCRINOL. 2024;15:1336402.","journal-title":"FRONT ENDOCRINOL"},{"issue":"1","key":"4822_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","volume":"18","author":"J Baek","year":"2022","unstructured":"Baek J, He C, Afshinnia F, Michailidis G, Pennathur S. Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nat Rev Nephrol. 2022;18(1):38\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4822_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajcnut.2024.08.015","volume":"120","author":"YC Jiang","year":"2024","unstructured":"Jiang YC, Lai K, Muirhead RP, Chung LH, Huang Y, James E, Liu XT, Wu J, Atkinson FS, Yan S, et al. Deep serum lipidomics identifies evaluative and predictive biomarkers for individualized glycemic responses following low-energy diet-induced weight loss: a prevention of diabetes through lifestyle intervention and population studies in Europe and around the world (PREVIEW) substudy. Am J Clin Nutr. 2024;120(4):864\u201378.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"4822_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00011-024-01943-z","volume":"73","author":"L Wang","year":"2024","unstructured":"Wang L, Yang G, Guo L, Yao L, Liu Y, Sha W. Olink proteomics and lipidomics analysis of serum from patients infected with non-tuberculous mycobacteria and Mycobacterium tuberculosis. Inflamm Research: Official J Eur Histamine Res Soc \u2026 Et Al ]. 2024;73(11):1945\u201360.","journal-title":"Inflamm Research: Official J Eur Histamine Res Soc \u2026 Et Al ]"},{"issue":"1","key":"4822_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40478-024-01864-2","volume":"12","author":"P Meier","year":"2024","unstructured":"Meier P, Glasmacher S, Salmen A, Chan A, Gertsch J. Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids. ACTA NEUROPATHOL COM. 2024;12(1):160.","journal-title":"ACTA NEUROPATHOL COM"},{"issue":"8","key":"4822_CR10","first-page":"565","volume":"13","author":"Y Deng","year":"2021","unstructured":"Deng Y, Wu Q, Chen W, Zhu L, Liu W, Xia F, Sun L, Lin X, Zeng R. Lipidomics reveals association of Circulating lipids with body mass index and outcomes in IgA nephropathy patients. J MOL CELL BIOL. 2021;13(8):565\u201375.","journal-title":"J MOL CELL BIOL"},{"key":"4822_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.nutr.18.1.39","volume":"18","author":"CJ Rebouche","year":"1998","unstructured":"Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. ANNU REV NUTR. 1998;18:39\u201361.","journal-title":"ANNU REV NUTR"},{"key":"4822_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.nu.03.070183.001313","volume":"3","author":"PR Borum","year":"1983","unstructured":"Borum PR, Carnitine. ANNU REV NUTR. 1983;3:233\u201359.","journal-title":"ANNU REV NUTR"},{"issue":"4 Suppl 4","key":"4822_CR13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0272-6386(03)00112-4","volume":"41","author":"C Hoppel","year":"2003","unstructured":"Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. AM J KIDNEY DIS. 2003;41(4 Suppl 4):S4\u201312.","journal-title":"AM J KIDNEY DIS"},{"issue":"1\u20132","key":"4822_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/A:1006826620218","volume":"180","author":"DJ Paulson","year":"1998","unstructured":"Paulson DJ. Carnitine deficiency-induced cardiomyopathy. MOL CELL BIOCHEM. 1998;180(1\u20132):33\u201341.","journal-title":"MOL CELL BIOCHEM"},{"key":"4822_CR15","doi-asserted-by":"crossref","unstructured":"Bignon Y, Wigger L, Ansermet C, Weger BD, Lagarrigue S, Centeno G, Durussel F, G\u00f6tz L, Ibberson M, Pradervand S et al. Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular circadian clock. J CLIN INVEST 2023;133(8).","DOI":"10.1172\/JCI167133"},{"issue":"4","key":"4822_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.kint.2023.12.010","volume":"105","author":"M Rivedal","year":"2024","unstructured":"Rivedal M, Mikkelsen H, Marti H, Liu L, Kiryluk K, Knoop T, Bjorneklett R, Haaskjold YL, Furriol J, Leh S, et al. Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy. KIDNEY INT. 2024;105(4):717\u201330.","journal-title":"KIDNEY INT"},{"key":"4822_CR17","doi-asserted-by":"publisher","first-page":"645988","DOI":"10.3389\/fimmu.2021.645988","volume":"12","author":"R Tang","year":"2021","unstructured":"Tang R, Meng T, Lin W, Shen C, Ooi JD, Eggenhuizen PJ, Jin P, Ding X, Chen J, Tang Y, et al. A partial picture of the Single-Cell transcriptomics of human IgA nephropathy. FRONT IMMUNOL. 2021;12:645988.","journal-title":"FRONT IMMUNOL"},{"key":"4822_CR18","doi-asserted-by":"publisher","first-page":"111754","DOI":"10.1016\/j.intimp.2024.111754","volume":"130","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu Y, Zhang Y, Zhang S, Zhao M, Peng Z, Xu H, Huang H. Characterization of macrophages in ischemia-reperfusion injury-induced acute kidney injury based on single-cell RNA-Seq and bulk RNA-Seq analysis. INT IMMUNOPHARMACOL. 2024;130:111754.","journal-title":"INT IMMUNOPHARMACOL"},{"issue":"13","key":"4822_CR19","doi-asserted-by":"publisher","first-page":"e2408753","DOI":"10.1002\/advs.202408753","volume":"12","author":"H Huang","year":"2025","unstructured":"Huang H, Han Y, Zhang Y, Zeng J, He X, Cheng J, Wang S, Xiong Y, Yin H, Yuan Q, et al. Deletion of pyruvate carboxylase in tubular epithelial cell promotes renal fibrosis by regulating SQOR\/cGAS\/STING-Mediated Glycolysis. ADV SCI. 2025;12(13):e2408753.","journal-title":"ADV SCI"},{"issue":"6","key":"4822_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145\u201359.","journal-title":"Cell"},{"issue":"5","key":"4822_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"JS Bhatti","year":"2017","unstructured":"Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. BBA-MOL BASIS DIS. 2017;1863(5):1066\u201377.","journal-title":"BBA-MOL BASIS DIS"},{"key":"4822_CR22","doi-asserted-by":"crossref","unstructured":"Andrieux P, Chevillard C, Cunha-Neto E, Nunes JPS. Mitochondria as a cellular hub in infection and inflammation. INT J MOL SCI 2021, 22(21).","DOI":"10.3390\/ijms222111338"},{"issue":"7","key":"4822_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tem.2024.10.009","volume":"36","author":"JM Delgado","year":"2025","unstructured":"Delgado JM, Pernas L. Mitochondria as sensors of intracellular pathogens. TRENDS ENDOCRIN MET. 2025;36(7):638\u201344.","journal-title":"TRENDS ENDOCRIN MET"},{"issue":"1","key":"4822_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. NAT COMMUN. 2020;11(1):102.","journal-title":"NAT COMMUN"},{"issue":"5","key":"4822_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1681\/ASN.2013111202","volume":"26","author":"T Kawakami","year":"2015","unstructured":"Kawakami T, Gomez IG, Ren S, Hudkins K, Roach A, Alpers CE, Shankland SJ, D\u2019Agati VD, Duffield JS. Deficient autophagy results in mitochondrial dysfunction and FSGS. J AM SOC NEPHROL. 2015;26(5):1040\u201352.","journal-title":"J AM SOC NEPHROL"},{"issue":"3","key":"4822_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1172\/JCI77084","volume":"125","author":"SK Mallipattu","year":"2015","unstructured":"Mallipattu SK, Horne SJ, D\u2019Agati V, Narla G, Liu R, Frohman MA, Dickman K, Chen EY, Ma\u2019Ayan A, Bialkowska AB, et al. Kr\u00fcppel-like factor 6 regulates mitochondrial function in the kidney. J CLIN INVEST. 2015;125(3):1347\u201361.","journal-title":"J CLIN INVEST"},{"issue":"7","key":"4822_CR27","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1681\/ASN.2015111277","volume":"27","author":"C Tang","year":"2016","unstructured":"Tang C, Dong Z. Mitochondria in kidney injury: when the power plant fails. J AM SOC NEPHROL. 2016;27(7):1869\u201372.","journal-title":"J AM SOC NEPHROL"},{"issue":"7","key":"4822_CR28","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1681\/ASN.2015040376","volume":"27","author":"N Tsuji","year":"2016","unstructured":"Tsuji N, Tsuji T, Ohashi N, Kato A, Fujigaki Y, Yasuda H. Role of mitochondrial DNA in septic AKI via Toll-Like receptor 9. J AM SOC NEPHROL. 2016;27(7):2009\u201320.","journal-title":"J AM SOC NEPHROL"},{"key":"4822_CR29","doi-asserted-by":"crossref","unstructured":"Zhang X, Agborbesong E, Li X. The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. INT J MOL SCI 2021, 22(20).","DOI":"10.3390\/ijms222011253"},{"issue":"4","key":"4822_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/ars.2016.6696","volume":"25","author":"K Sharma","year":"2016","unstructured":"Sharma K. Obesity and diabetic kidney disease: role of oxidant stress and redox balance. ANTIOXID REDOX SIGN. 2016;25(4):208\u201316.","journal-title":"ANTIOXID REDOX SIGN"},{"issue":"4","key":"4822_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.bbagen.2013.11.007","volume":"1840","author":"R Blake","year":"2014","unstructured":"Blake R, Trounce IA. Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta. 2014;1840(4):1404\u201312.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"4822_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-021-00883-8","volume":"43","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Novak J. IgA glycosylation and immune complex formation in IgAN. SEMIN IMMUNOPATHOL. 2021;43(5):669\u201378.","journal-title":"SEMIN IMMUNOPATHOL"},{"issue":"12","key":"4822_CR33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.molmed.2015.10.003","volume":"21","author":"T Robert","year":"2015","unstructured":"Robert T, Berthelot L, Cambier A, Rondeau E, Monteiro RC. Molecular insights into the pathogenesis of IgA nephropathy. TRENDS MOL MED. 2015;21(12):762\u201375.","journal-title":"TRENDS MOL MED"},{"issue":"7","key":"4822_CR34","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ckj\/sfad025","volume":"16","author":"M Gentile","year":"2023","unstructured":"Gentile M, Sanchez-Russo L, Riella LV, Verlato A, Manrique J, Granata S, Fiaccadori E, Pesce F, Zaza G, Cravedi P. Immune abnormalities in IgA nephropathy. CLIN KIDNEY J. 2023;16(7):1059\u201370.","journal-title":"CLIN KIDNEY J"},{"issue":"11","key":"4822_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.tcb.2024.09.002","volume":"34","author":"C Yan","year":"2024","unstructured":"Yan C, Liu X, Xu H, Wang L. Cytoplasmic MtDNA clearance suppresses inflammatory immune responses. TRENDS CELL BIOL. 2024;34(11):897\u2013900.","journal-title":"TRENDS CELL BIOL"},{"key":"4822_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","volume":"92","author":"LE Newman","year":"2023","unstructured":"Newman LE, Shadel GS. Mitochondrial DNA release in innate immune signaling. ANNU REV BIOCHEM. 2023;92:299\u2013332.","journal-title":"ANNU REV BIOCHEM"},{"issue":"5","key":"4822_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"C Tang","year":"2021","unstructured":"Tang C, Cai J, Yin X, Weinberg JM, Venkatachalam MA, Dong Z. Mitochondrial quality control in kidney injury and repair. NAT REV NEPHROL. 2021;17(5):299\u2013318.","journal-title":"NAT REV NEPHROL"},{"key":"4822_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/978-3-319-55330-6_27","volume":"982","author":"P Duann","year":"2017","unstructured":"Duann P, Lin P. Mitochondria damage and kidney disease. ADV EXP MED BIOL. 2017;982:529\u201351.","journal-title":"ADV EXP MED BIOL"},{"issue":"1","key":"4822_CR39","doi-asserted-by":"publisher","first-page":"16068","DOI":"10.1038\/s41598-019-52535-5","volume":"9","author":"BC Yu","year":"2019","unstructured":"Yu BC, Cho N, Park S, Kim H, Choi SJ, Kim JK, Hwang SD, Gil H, Lee EY, Jeon JS, et al. IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers. SCI REP-UK. 2019;9(1):16068.","journal-title":"SCI REP-UK"},{"issue":"1","key":"4822_CR40","doi-asserted-by":"publisher","first-page":"2182133","DOI":"10.1080\/0886022X.2023.2182133","volume":"45","author":"J Liu","year":"2023","unstructured":"Liu J, Wang R, Luo N, Li Z, Mao H, Zhou Y. Mitochondrial DNA copy number in peripheral blood of IgA nephropathy: a cross-sectional study. Ren Fail. 2023;45(1):2182133.","journal-title":"Ren Fail"},{"issue":"3 Suppl 1","key":"4822_CR41","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1053\/ajkd.2003.50099","volume":"41","author":"G Bellinghieri","year":"2003","unstructured":"Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and Hemodialysis. AM J KIDNEY DIS. 2003;41(3 Suppl 1):S116\u201322.","journal-title":"AM J KIDNEY DIS"},{"key":"4822_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.bi.57.070188.001401","volume":"57","author":"LL Bieber","year":"1988","unstructured":"Bieber LL, Carnitine. ANNU REV BIOCHEM. 1988;57:261\u201383.","journal-title":"ANNU REV BIOCHEM"},{"issue":"14","key":"4822_CR43","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.addr.2009.04.024","volume":"61","author":"VA Zammit","year":"2009","unstructured":"Zammit VA, Ramsay RR, Bonomini M, Arduini A. Carnitine, mitochondrial function and therapy. ADV DRUG DELIVER REV. 2009;61(14):1353\u201362.","journal-title":"ADV DRUG DELIVER REV"},{"issue":"5","key":"4822_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"APJ de Vries","year":"2014","unstructured":"de Vries APJ, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, D\u2019Agati VD, Lamb HJ, Pongrac Barlovic D, Hojs R, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. LANCET DIABETES ENDO. 2014;2(5):417\u201326.","journal-title":"LANCET DIABETES ENDO"},{"issue":"10","key":"4822_CR45","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/ar.24302","volume":"303","author":"G Kanzaki","year":"2020","unstructured":"Kanzaki G, Tsuboi N, Shimizu A, Yokoo T. Human nephron number, hypertension, and renal pathology. ANAT REC. 2020;303(10):2537\u201343.","journal-title":"ANAT REC"},{"key":"4822_CR46","doi-asserted-by":"crossref","unstructured":"Gewin LS. Sugar or fat? Renal tubular metabolism reviewed in health and disease. Nutrients. 2021;13(5).","DOI":"10.3390\/nu13051580"},{"key":"4822_CR47","doi-asserted-by":"publisher","first-page":"786599","DOI":"10.3389\/fphys.2021.786599","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen S, Chen J, Li S, Guo F, Li A, Wu H, Chen J, Pan Q, Liao S, Liu H, et al. High-Fat Diet-Induced renal proximal tubular inflammatory injury: emerging risk factor of chronic kidney disease. FRONT PHYSIOL. 2021;12:786599.","journal-title":"FRONT PHYSIOL"},{"issue":"1","key":"4822_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko Y, Han SH, Chinga F, Park ASD, Tao J, Sharma K, Pullman J, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. NAT MED. 2015;21(1):37\u201346.","journal-title":"NAT MED"},{"issue":"14","key":"4822_CR49","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.7150\/ijbs.74675","volume":"18","author":"J Wu","year":"2022","unstructured":"Wu J, Shao X, Shen J, Lin Q, Zhu X, Li S, Li J, Zhou W, Qi C, Ni Z. Downregulation of PPARalpha mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. INT J BIOL SCI. 2022;18(14):5438\u201358.","journal-title":"INT J BIOL SCI"},{"issue":"Suppl 1","key":"4822_CR50","first-page":"S45","volume":"25","author":"RL Mynatt","year":"2009","unstructured":"Mynatt RL. Carnitine and type 2 diabetes. DIABETES-METAB RES. 2009;25(Suppl 1):S45\u20139.","journal-title":"DIABETES-METAB RES"},{"key":"4822_CR51","doi-asserted-by":"crossref","unstructured":"Virmani MA, Cirulli M. The role of l-Carnitine in Mitochondria, prevention of metabolic inflexibility and disease initiation. Int J Mol Sci 2022, 23(5).","DOI":"10.3390\/ijms23052717"},{"key":"4822_CR52","doi-asserted-by":"crossref","unstructured":"Savic D, Hodson L, Neubauer S, Pavlides M. The importance of the fatty acid transporter l-carnitine in non-alcoholic fatty liver disease (NAFLD). Nutrients 2020, 12(8).","DOI":"10.3390\/nu12082178"},{"issue":"9","key":"4822_CR53","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.clnu.2024.07.019","volume":"43","author":"N Dai","year":"2024","unstructured":"Dai N, Diao Z, Huang H, Li Z, Yang R, Liu W. Disturbed carnitine metabolism is independently correlated with sarcopenia and prognosis in patients on Hemodialysis. CLIN NUTR. 2024;43(9):2019\u201327.","journal-title":"CLIN NUTR"},{"issue":"8","key":"4822_CR54","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s00467-021-05101-z","volume":"36","author":"HA Morgans","year":"2021","unstructured":"Morgans HA, Chadha V, Warady BA. The role of carnitine in maintenance Dialysis therapy. PEDIATR NEPHROL. 2021;36(8):2545\u201351.","journal-title":"PEDIATR NEPHROL"},{"issue":"5","key":"4822_CR55","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/eci.12609","volume":"46","author":"B Waagsbo","year":"2016","unstructured":"Waagsbo B, Svardal A, Ueland T, Landro L, Oktedalen O, Berge RK, Flo TH, Aukrust P, Damas JK. Low levels of short- and medium-chain acylcarnitines in HIV-infected patients. EUR J CLIN INVEST. 2016;46(5):408\u201317.","journal-title":"EUR J CLIN INVEST"},{"issue":"8","key":"4822_CR56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1515\/jpem-2020-0741","volume":"34","author":"PD Manta-Vogli","year":"2021","unstructured":"Manta-Vogli PD, Schulpis KH, Loukas YL, Dotsikas Y. Quantitation and evaluation of perinatal medium-chain and long-chain acylcarnitine blood concentrations in 12,000 full-term breastfed newborns. J PEDIATR ENDOCR MET. 2021;34(8):1023\u201330.","journal-title":"J PEDIATR ENDOCR MET"},{"issue":"12","key":"4822_CR57","first-page":"CD13601","volume":"12","author":"N Nishioka","year":"2022","unstructured":"Nishioka N, Luo Y, Taniguchi T, Ohnishi T, Kimachi M, Ng RC, Watanabe N. Carnitine supplements for people with chronic kidney disease requiring Dialysis. COCHRANE DB SYST REV. 2022;12(12):CD13601.","journal-title":"COCHRANE DB SYST REV"},{"key":"4822_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12986-018-0328-1","volume":"16","author":"F Xia","year":"2019","unstructured":"Xia F, Zhu L, Xu C, Wu Q, Chen W, Zeng R, Deng Y. Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy. NUTR METAB. 2019;16:2.","journal-title":"NUTR METAB"},{"issue":"10","key":"4822_CR59","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347(10):738\u201348.","journal-title":"N Engl J Med"},{"issue":"8","key":"4822_CR60","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/gfg207","volume":"18","author":"CC Geddes","year":"2003","unstructured":"Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC. A tricontinental view of IgA nephropathy. Nephrol Dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association. 2003;18(8):1541\u20138.","journal-title":"Nephrol Dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"3","key":"4822_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000354646","volume":"38","author":"Z Duan","year":"2013","unstructured":"Duan Z, Cai G, Chen Y, Liang S, Liu S, Wu J, Qiu Q, Lin S, Zhang X, Chen X. Aging promotes progression of IgA nephropathy: a systematic review and meta-analysis. AM J NEPHROL. 2013;38(3):241\u201352.","journal-title":"AM J NEPHROL"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04822-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:02:29Z","timestamp":1774436549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04822-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4822"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04822-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Review Board of the Xiangya Hospital of Central South University approved the present study (No. 202004194). Informed consent was obtained from all participants in this study. This study had been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}